RxSight, Inc. (RXST) investor relations documents from the company's IR site: 6 presentations, 34 press releases; latest deck 2026-08-05. Read in-app with summaries. First-party data.
Corporate Presentation: RxSight is an ophthalmic medical device company whose core value proposition is its adjustable intraocular lens (IOL) platform, highlighted by a $200M Alcon partnership.
RXST overview · RXST earnings · RXST financials · RXST KPIs · RXST documents · RXST ownership · RXST peers
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.